HTLV-I infection is crippling

BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6923.273b (Published 22 January 1994) Cite this as: BMJ 1994;308:273
  1. J A Copplestone,
  2. A G Prentice,
  3. M D Hamon,
  4. J Gawler,
  5. N Anderson
  1. Department of Haematology, Derriford Hospital, Plymouth PL6 8AP
  2. Department of Neurology, St Bartholomew's Hospital, London EC1A 7BE
  3. Blood Services South West, Southmead Hospital, Bristol BS10 5ND.

    EDITOR, - M Brennan and colleagues1 and A G Dalgleish2 conclude that the low prevalence of infection with human T cell leukaemia/lymphoma virus type I (HTLV-I) in Britain means that screening blood donors for antibodies to this virus is not cost effective. Though we accept the economic arguments, the consequences of such a policy can be tragic for …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial